Compound Detail
CHEMBL328295
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL328295 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | LJMGWHXMJIZVDQ-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
266.3
MW (Da)
3.28
ALogP
5
HBA
1
HBD
81.0
PSA (Ų)
0.58
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 5.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Epidermal growth factor receptor CHEMBL203 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Epidermal growth factor receptor | IC50 | = | 5000.0 | nM | 5.3 | Concentration required to inhibit the phosphorylation of a 14-residue fragment o... | 8568816 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 8568816 | 10.1021/jm9503613 | Epidermal growth factor receptor | 1 |
| 26619389 | 10.1016/j.ejmech.2015.11.016 | Leishmania major | 1 |
Data from ChEMBL 36 via Core Engine